These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ten years of gene therapy for primary immune deficiencies. Aiuti A; Roncarolo MG Hematology Am Soc Hematol Educ Program; 2009; ():682-9. PubMed ID: 20008254 [TBL] [Abstract][Full Text] [Related]
4. Gene therapy for PIDs: progress, pitfalls and prospects. Mukherjee S; Thrasher AJ Gene; 2013 Aug; 525(2):174-81. PubMed ID: 23566838 [TBL] [Abstract][Full Text] [Related]
5. Gene therapy for primary immunodeficiencies: Part 2. Aiuti A; Bacchetta R; Seger R; Villa A; Cavazzana-Calvo M Curr Opin Immunol; 2012 Oct; 24(5):585-91. PubMed ID: 22909900 [TBL] [Abstract][Full Text] [Related]
6. Lentiviral vectors for the treatment of primary immunodeficiencies. Farinelli G; Capo V; Scaramuzza S; Aiuti A J Inherit Metab Dis; 2014 Jul; 37(4):525-33. PubMed ID: 24619149 [TBL] [Abstract][Full Text] [Related]
7. Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases. Candotti F Int J Hematol; 2014 Apr; 99(4):383-92. PubMed ID: 24488786 [TBL] [Abstract][Full Text] [Related]
8. Gene Therapies for Primary Immune Deficiencies. Kohn LA; Kohn DB Front Immunol; 2021; 12():648951. PubMed ID: 33717203 [TBL] [Abstract][Full Text] [Related]
9. Gene therapy of primary T cell immunodeficiencies. Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M Gene; 2013 Aug; 525(2):170-3. PubMed ID: 23583799 [TBL] [Abstract][Full Text] [Related]